IP Library › Assignment 020667/0643
Patent Assignment
Reel/Frame 020667/0643

Change of Name

Recorded: 2008-03-18 Pages: 9
Assignor
IDEC PHARMACEUTICALS CORP.
Executed: 2003-11-12
Assignee
BIOGEN IDEC INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (3)
Expression and Use of Anti-CD20 Antibodies
Patent: 7,381,560 →
Application: 09/911,692 →
Publication: US 2003/0095963
Anti-CD20 Antibodies
Patent: 7,422,739 →
Application: 09/911,703 →
Publication: US 2002/0197255
Expression and Use of Anti-CD20 Antibodies
Patent: 7,744,877 →
Application: 10/238,681 →
Publication: US 2003/0147885
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 5, 2001
From: ANDERSON, DARRELL R.; HANNA, NABIL; LEONARD, JOHN E.; NEWMAN, ROLAND A.
To: IDEC PHARMACEUTICALS CORPORATION
Reel/Frame 012297/0365 →
Merger Feb 12, 2008
From: IDEC PHARMACEUTICALS CORP. (CALIFORNIA)
To: IDEC PHARMACEUTICALS CORP. (DELAWARE)
Reel/Frame 020498/0550 →
Change of Name Apr 30, 2015
From: BIOGEN IDEC INC.
To: BIOGEN INC.
Reel/Frame 035552/0202 →